Version history

{
  "session_id": "sess_SDA-BIOMNI-SCRNA_AN-248caecc",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "mini-max",
  "action": "propose",
  "content": "\n\n# Novel Hypotheses: Cell State Discovery in Alzheimer's Disease via Standardized scRNA-seq\n\n---\n\n## Hypothesis 1: Disease-Associated Microglial States Represent Continuum Rather Than Discrete Categories\n\n**Description:** Standardized scRNA-seq processing across multiple brain regions will reveal that AD-associated microglial states exist on a continuous spectrum rather than as binary \"homeostatic\" vs. \"disease-associated\" categories. Automated annotation pipelines incorporating velocity analysis will identify transitional states with mixed gene expression programs (e.g., concurrent TREM2 upregulation and inflammatory marker expression), suggesting these cells actively oscillate between protective and damaging functions.\n\n**Target Gene/Protein:** TREM2, P2RY12, CD68, IL1B (module analysis)\n\n**Confidence Score:** 0.78\n\n**Evidence Basis:** Keren-Shaul et al. (2017) identified disease-associated microglia (DAM) in mouse models of AD. Subsequent human studies (Mathys et al., 2019; Grubman et al., 2019) revealed species differences but conserved activation programs. The continuum hypothesis is supported by single-cell ATAC-seq showing gradual chromatin accessibility changes rather than sharp transitions.\n\n---\n\n## Hypothesis 2: Astrocyte Reactivity Shows Brain-Region-Specific Transcriptional Programs Coordinated with Local Amyloid Burden\n\n**Description:** Standardized multi-regional scRNA-seq will identify at least three distinct astrocyte reactivity states that correlate with local amyloid-β or tau pathology burden: (1) a \"pan-reactive\" state with universal stress markers, (2) a \"synaptic-supportive\" state upregulating complement inhibitors, and (3) a \"metabolic-compromised\" state characterized by glucose transporter dysregulation. These states will show spatial clustering around amyloid plaques versus neurofibrillary tangles.\n\n**Target Gene/Protein:** GFAP, S100B, AQP4, SPARC, CLU (clusterin), APOE\n\n**Confidence Score:** 0.72\n\n**Evidence Basis:** Astrocyte reactivity in AD is well-documented but typically treated as monolithic. Studies have shown astrocyte-specific proteomic changes in AD (Daidzic et al., 2023), and transcriptomic analyses reveal diverse activation states across neurodegenerative conditions (Zamanian et al., 2012; Escott-Price et al., 2019). Multi-regional analysis will test whether regional pathology selectively induces specific programs.\n\n---\n\n## Hypothesis 3: Specific Excitatory Neuron Subtypes Display Proteostasis Collapse Signatures Prior to Neurodegeneration\n\n**Description:** Automated annotation of neuronal populations will identify a novel \"proteostasis-compromised\" state characterized by co-upregulation of unfolded protein response (UPR) effectors, autophagy machinery components, and ribosomal stress markers, without overt cell death markers. This state will be enriched in layer 2/3 excitatory neurons of the entorhinal cortex (vulnerable region) compared to dentate granule cells (relatively resistant), suggesting cell-type-specific proteostatic vulnerability thresholds.\n\n**Target Gene/Protein:** ATF4, XBP1, HSPA5 (BiP), GABARAP, RPN2, NFL (neurofilament light chain as stress readout)\n\n**Confidence Score:** 0.68\n\n**Evidence Basis:** Endoplasmic reticulum stress and UPR activation are established features of AD neurons (Scheffler et al., 2012; Duran-Aniotz et al., 2023). Layer 2/3 entorhinal cortex neurons show early tau pathology and neurodegeneration in AD. However, whether a specific \"pre-collapse\" transcriptional state exists before cell death has not been systematically characterized via scRNA-seq.\n\n---\n\n## Hypothesis 4: Oligodendrocyte Precursor Cells Exhibit a \"Remyelination-Arrested\" State Specific to White Matter Tracts Adjacent to AD Pathology\n\n**Description:** OPCs in AD brains will show a distinct transcriptional state characterized by proliferation markers (PDGFRA, PCNA) coupled with failure to upregulate differentiation promoters (SOX10, MYRF, MBP), representing an \"arrested\" state unable to complete oligodendrocyte differentiation. This state will be enriched in subcortical white matter and corpus callosum compared to gray matter regions, suggesting that local demyelination or amyloid deposition disrupts the normal OPC differentiation switch.\n\n**Target Gene/Protein:** PDGFRA, PCNA, MYRF, SOX10, CNP, MOG\n\n**Confidence Score:** 0.65\n\n**Evidence Basis:** White matter abnormalities and oligodendrocyte dysfunction are increasingly recognized in AD (Nasrabady et al., 2018;文献). OPCs fail to differentiate in aging and neurodegeneration, but multi-regional profiling of this failure mode in human AD has not been comprehensively performed. Standardized processing will enable cross-study comparison of OPC states.\n\n---\n\n## Hypothesis 5: Automated Annotation Will Identify a Novel \"Vascular-Interactive\" Cell State at the Blood-Brain Barrier Interface\n\n**Description:** Standardized scRNA-seq pipelines will reveal a transitional cell state at the neurovascular unit characterized by mixed identity markers (endothelial-pericyte-astrocyte hybrid signature) and pro-inflammatory cytokine production. This state will be enriched in prefrontal cortex and hippocampus (regions with high vascular pathology burden) and will correlate with APOE ε4 carrier status, suggesting genetic modulation of BBB breakdown programs.\n\n**Target Gene/Protein:** CLDN5 (endothelial), PDGFRB (pericyte), AQP4 (astrocyte endfeet), VEGFA, IL6, APOE\n\n**Confidence Score:** 0.62\n\n**Evidence Basis:** APOE ε4 is strongly linked to BBB dysfunction and pericyte injury in AD (Blanchard et al., 2022). Single-nucleus studies have identified mixed transitional states in brain vasculature, but whether these represent genuine cellular intermediates or doublet artifacts remains unresolved. Standardized processing with doublet detection will distinguish these possibilities.\n\n---\n\n## Hypothesis 6: Cell-Type-Specific Metabolic Reprogramming Reveals Niche-Dependent Adaptation States Across AD-Vulnerable and Resistant Regions\n\n**Description:** Multi-regional analysis will reveal that neurons, astrocytes, and microglia employ distinct metabolic adaptation strategies in response to AD pathology. Neurons will show mitochondrial dysfunction signatures, astrocytes will display metabolic cooperativity shifts (lactate shuttle upregulation), and microglia will exhibit glycolytic-inflammatory coupling. The ratio of these metabolic states will differ systematically between AD-vulnerable (entorhinal cortex, hippocampus) and relatively spared (cerebellum, primary motor cortex) regions.\n\n**Target Gene/Protein:** MT-ND genes (mitochondrial complex I), LDHA (glycolysis), MCT1/SLC16A1 (lactate transport), HIF1A, AMPK subunits\n\n**Confidence Score:** 0.70\n\n**Evidence Basis:** Metabolic dysfunction is a core feature of AD pathophysiology (Cai et al., 2012). Neuronal mitochondrial deficits are well-documented, while astrocytic and microglial metabolic shifts are emerging areas of investigation. Cross-regional comparison of metabolic states has been limited by batch effects in single-cell studies—standardized pipelines will address this limitation.\n\n---\n\n## Hypothesis 7: Cross-Dataset Integration via Automated Annotation Will Uncover a Universal \"Neurodegeneration Module\" Present Across Cell Types\n\n**Description:** When standardized scRNA-seq data from multiple AD cohorts and brain regions are processed through automated annotation pipelines, a conserved gene co-expression module will emerge across neurons, glia, and vascular cells, representing a universal cellular stress response to AD pathology. This module will include genes involved in RNA splicing, proteostasis, and stress granule formation, and will be distinct from normal aging-associated transcriptional changes.\n\n**Target Gene/Protein:** TIA1, G3BP1 (stress granule components), HNRNPA1, SNRPG, PSMA2, PSMC2 (proteasome), SRSF2\n\n**Confidence Score:** 0.58\n\n**Evidence Basis:** Stress granules and RNA metabolism dysregulation are implicated in AD and related tauopathies (Wolozin, 2012; Zhang et al., 2022). Convergent stress responses across cell types would support a \"common final pathway\" model of neurodegeneration, but systematic comparison across cell types and brain regions remains technically challenging due to batch effects and annotation inconsistencies. This hypothesis tests whether standardized pipelines can reveal such convergent programs.\n\n---\n\n## Summary Table\n\n| # | Hypothesis Title | Primary Target | Confidence |\n|---|------------------|----------------|-------------|\n| 1 | Microglial Continuum States | TREM2/P2RY12 | 0.78 |\n| 2 | Region-Specific Astrocyte Reactivity | GFAP, APOE | 0.72 |\n| 3 | Proteostasis Collapse in Excitatory Neurons | UPR components | 0.68 |\n| 4 | OPC Remyelination Arrest | SOX10, MYRF | 0.65 |\n| 5 | Vascular-Interactive BBB States | CLDN5, APOE | 0.62 |\n| 6 | Niche-Dependent Metabolic Adaptation | Mitochondrial genes | 0.70 |\n| 7 | Universal Neurodegeneration Module | Stress granule genes | 0.58 |\n\n---\n\n**Key Methodological Assumption:** These hypotheses assume that standardization of scRNA-seq processing (cell calling, normalization, batch correction via Harmony/BBKNN, and automated annotation via CellTypist/Scanply) will enable reliable cross-study and cross-regional comparison that was previously impossible due to technical batch effects.\n\n**Highest Priority Test:** Hypothesis 1 (microglial continuum) is most immediately testable given existing DAM literature and available public datasets (Mayo Clinic RNA-seq, MSBB, ROSMAP) that can be reprocessed through standardized pipelines.",
  "tokens_used": "2400"
}